http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08231419-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c8d4dc7bd1a30d8fda907fceaeb4e69 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 |
filingDate | 1995-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64ccd31c505f392d79268fad82ee16f1 |
publicationDate | 1996-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-H08231419-A |
titleOfInvention | Upper gastrointestinal disease therapeutic agent |
abstract | (57) [Summary] [Structure] Hepatocyte growth factor (eg 1) The molecular weight estimated by SDS-PAGE is about 76-92K; 2) it has the activity of growing hepatocytes; 3) 80 ° C, The activity is inactivated by heat treatment for 10 minutes; 4) The activity is inactivated by digestion with trypsin and chymotrypsin; 5) A prophylactic / therapeutic agent for upper gastrointestinal diseases, which contains as an active ingredient a substance having a strong affinity for heparin). [Effect] HGF, which is an active ingredient, has an anti-ulcer action, and is useful for the prevention and treatment of gastric ulcer, duodenal ulcer, chronic or acute gastritis, and the like. |
priorityDate | 1995-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 95.